To understand the biology of diseased organs, researchers can use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
Computational researchers have developed a computer program which has revealed a previously unknown combination of drugs that may be the answer to triple-negative breast cancer.
Researchers from the Mayo Clinic recommends genetic testing for all pancreatic cancer patients as the new standard of care, after finding six genetic mutations in patients with no family history of the disease.
The Swiss drugmaker has clearly noticed the genomic profiling group’s ability to personalise cancer care, now that it will take complete ownership of the company.
Researchers have identified a new subtype of prostate cancer that occurs in about 7% of patients with advanced disease. This subset of tumours was responsive to immunotherapy treatment.
Researchers have found that by helping to form clots within tumours, immune cells that flock to a particular type of lung cancer are actually building a foundation for the tumour to spread within the body.
Researchers have discovered that tumour cells reprogram metabolic pathways to gain control over a type of immune cell that allows cancer growth.
A patient with metastatic breast cancer has made a dramatic recovery after receiving a personalised therapy using her own cells.